Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Feb 13, 2020, before the open
10-K filed Feb 13, 2020, 44 days after period end · 0001558370-20-000779
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $126.30M | $130.69M | $94.21M | $87.46M |
| Net Income | $47.86M | -$15.49M | $12.09M | -$13.51M |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| $0.30 |
| -$0.10 |
| $0.08 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.